Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume Publish Ahead of Print, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-06-26
DOI
10.1097/med.0000000000000646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beta-Cell Stress Shapes CTL Immune Recognition of Preproinsulin Signal Peptide by Post-Transcriptional Regulation of Endoplasmic Reticulum Aminopeptidase 1
- (2020) Sofia Thomaidou et al. DIABETES
- Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
- (2020) Pieter F. de Groot et al. DIABETOLOGIA
- Hybrid Insulin Peptides are Recognized by Human T Cells in the Context of DRB1*04:01
- (2020) David Arribas-Layton et al. DIABETES
- Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis
- (2020) Pia Leete et al. DIABETOLOGIA
- Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes
- (2020) Paolo Pozzilli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
- (2020) Kevan C. Herold et al. DIABETES OBESITY & METABOLISM
- A combined risk score enhances prediction of type 1 diabetes among susceptible children
- (2020) Lauric A. Ferrat et al. NATURE MEDICINE
- Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes
- (2020) Tatjana Nikolic et al. Lancet Diabetes & Endocrinology
- Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
- (2020) Bart O. Roep et al. Nature Reviews Endocrinology
- Beta cells in type 1 diabetes: mass and function; sleeping or dead?
- (2019) Richard A. Oram et al. DIABETOLOGIA
- Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response
- (2019) Anu Sharma et al. CLINICAL CANCER RESEARCH
- Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review
- (2019) Jeroen M.k. de Filette et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance
- (2019) Jason Gaglia et al. BIOCHEMISTRY
- Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
- (2019) Manuela Battaglia et al. DIABETES CARE
- Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes
- (2019) Laura A. Claessens et al. DIABETOLOGIA
- New Frontiers in the Treatment of Type 1 Diabetes
- (2019) Jeremy T. Warshauer et al. Cell Metabolism
- Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes
- (2018) Florence Anquetil et al. DIABETES
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- (2018) Angeliki M. Stamatouli et al. DIABETES
- Abnormal islet sphingolipid metabolism in type 1 diabetes
- (2018) Laurits J. Holm et al. DIABETOLOGIA
- Verapamil and beta cell function in adults with recent-onset type 1 diabetes
- (2018) Fernando Ovalle et al. NATURE MEDICINE
- T cells specific for post-translational modifications escape intrathymic tolerance induction
- (2018) Bruno Raposo et al. Nature Communications
- Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
- (2018) Kevin C. Osum et al. Scientific Reports
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens
- (2018) Romualdo Barroso-Sousa et al. JAMA Oncology
- Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark
- (2018) Julie C Antvorskov et al. BMJ-British Medical Journal
- PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction
- (2018) Maikel L. Colli et al. EBioMedicine
- Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study
- (2018) Andreas Beyerlein et al. JOURNAL OF MEDICAL GENETICS
- A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults
- (2018) Lea B. S. Hansen et al. Nature Communications
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
- (2018) Bart O Roep et al. Lancet Diabetes & Endocrinology
- Akkermansia muciniphilainduces gut microbiota remodelling and controls islet autoimmunity in NOD mice
- (2017) Arno Hänninen et al. GUT
- Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes
- (2017) Maria J L Kracht et al. NATURE MEDICINE
- Type 1 diabetes induction in humanized mice
- (2017) Shulian Tan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
- (2017) Kelen C. R. Malmegrim et al. Frontiers in Immunology
- Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
- (2017) Pieter F. de Groot et al. PLoS One
- Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes
- (2016) Aaron W. Michels et al. DIABETES
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Tolerance is established in polyclonal CD4+ T cells by distinct mechanisms, according to self-peptide expression patterns
- (2016) Deepali Malhotra et al. NATURE IMMUNOLOGY
- Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
- (2016) T. Delong et al. SCIENCE
- The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
- (2015) Aleksandar D. Kostic et al. Cell Host & Microbe
- Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
- (2015) Martha Campbell-Thompson et al. DIABETES
- Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray
- (2015) Nicky JC Woittiez et al. Immunotherapy
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
- (2014) T. Orban et al. DIABETES
- Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors
- (2014) Richard A. Oram et al. DIABETES CARE
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
- (2013) M. van Lummel et al. DIABETES
- Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
- (2013) Tatjana Nikolic et al. Frontiers in Immunology
- Preventing -Cell Loss and Diabetes With Calcium Channel Blockers
- (2012) G. Xu et al. DIABETES
- Fecal Microbiota Composition Differs Between Children With -Cell Autoimmunity and Those Without
- (2012) M. C. de Goffau et al. DIABETES
- Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes
- (2012) I. Marhfour et al. DIABETOLOGIA
- Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes
- (2012) Martha Campbell-Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Islet inflammation and CXCL10 in recent-onset type 1 diabetes
- (2010) B. O. Roep et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies
- (2009) P. Gillard et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More